EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant Bacteria

Ka Mun Chung, Sue C Nang, Swee Seong Tang

Pharmaceuticals · 24.09.2023 · 16 (10) · 1347

DOI: 10.3390/ph16101347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 24.09.2023. Verfasst von Ka Mun Chung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Molecular Genetics, Institute of Biological Sciences, Faculty of Sciences, University of Malaya, Kuala Lumpur 50603, Mal…. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, (Fundamental Research Grant Scheme) of the Ministry of Higher Education, Malaysia, (Others MOHE—Top 100 (IIRG)-IISS Grant) of the University of Malaya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the urgency due to the rapid emergence of multidrug-resistant (MDR) bacteria, bacteriophages (phages), which are viruses that specifically target and kill bacteria, are rising as a potential alternative to antibiotics. In recent years, researchers have begun to elucidate the safety aspects of phage therapy with the aim of ensuring safe and effective clinical applications. While phage therapy has generally been demonstrated to be safe and tolerable among animals and humans, the current research on phage safety monitoring lacks sufficient and consistent data. This emphasizes the critical need for a standardized phage safety assessment to ensure a more reliable evaluation of its safety profile. Therefore, this review aims to bridge the knowledge gap concerning phage safety for treating MDR bacterial infections by covering various aspects involving phage applications, including phage preparation, administration, and the implications for human health and the environment.

Schlagwörter

Stichwörter der Autor:innen

animal studiesantibiotic-resistant bacteriaclinical trialsendotoxinhuman healthphage safetyphage-resistant bacteria

Autor:innen und Institutionen

  • Division of Microbiology and Molecular Genetics, Institute of Biological Sciences, Faculty of Sciences, University of Malaya, Kuala Lumpur 50603, Malaysia.
  • Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Centre for Research in Biotechnology for Agriculture, University of Malaya, Kuala Lumpur 50603, Malaysia.

Förderung

  • Ministry of Higher Education
  • (Fundamental Research Grant Scheme) of the Ministry of Higher Education, Malaysia
  • (Others MOHE—Top 100 (IIRG)-IISS Grant) of the University of Malaya

Zitieren

APA

Chung, K. M., Nang, S. C., & Tang, S. S. (2023). The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant Bacteria. Pharmaceuticals, 16(10), 1347. https://doi.org/10.3390/ph16101347

Vancouver

Chung KM, Nang SC, Tang SS. The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant Bacteria. Pharmaceuticals. 2023;16(10):1347. doi:10.3390/ph16101347

BibTeX
@article{Chung2023,
  author = {Chung, Ka Mun and Nang, Sue C and Tang, Swee Seong},
  title = {The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant Bacteria},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {10},
  pages = {1347},
  doi = {10.3390/ph16101347}
}
Kostenlos starten →